Capital World Investors
GTHX

Capital World Investors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Capital World Investors’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-84,400
Closed -$1.4M – 552
2019
Q1 		$1.4M Sell
84,400
-1,122,600
-93% -$21.3M ﹤0.01% 513
2018
Q4 		$23.1M Sell
1,207,000
-8,000
-0.7% -$300K 0.01% 423
2018
Q3 		$63.5M Buy
1,215,000
+202,000
+20% +$11M 0.02% 358
2018
Q2 		$44M Buy
1,013,000
+538,000
+113% +$23.1M 0.01% 376
2018
Q1 		$17.6M Buy
+475,000
New +$12.7M ﹤0.01% 446

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital World Investors's GTHX Position: Q2 2019 in Review

Capital World Investors sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2019, closing a stake of 84,400 shares — an estimated $1.4M sold.

Capital World Investors first reported a position in GTHX in Q1 2018 and held it in 5 quarters. The position peaked at $63.5M in Q3 2018. 94 funds tracked by Wall St. Rank hold GTHX as of Q2 2019.

  • Capital World Investors reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Capital World Investors sold 84,400 G1 Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.4M.
  • Capital World Investors first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and held it in 5 quarters.
  • Capital World Investors's G1 Therapeutics, Inc. Common Stock position peaked at $63.5M in Q3 2018.
  • 94 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Capital World Investors's 13F filing for Q2 2019, filed 14 Aug 2019.